-
Tuesday evening, Celine Galvagnion gave the Medicinens Verden talk, “What can our skin and brain cells tell us about Parkinson’s?” in front of an engaged and very participating audience at Panum. Thank you all!👌 👏 Céline Galvagnion took us on an instructive journey on how our brain and skin cells can be used to understand the progression of Parkinson’s Disease. This knowledge can be used to design efficient biomarkers and medical treatments against this currently incurable disease that 12.000 people are suffering from, only in Denmark, and so many more worldwide. This was the last talk in the Spring season…
-
11.10.2023 Céline received a 131.300 DKK grant from Parkinsonforeningen for the project “Brain glucosylceramide changes associated with disease duration and familial Parkinson Disease.” This project aims to quantify changes in glucosylceramide levels associated with Parkinson’s Disease in post-mortem brain samples.
-
We would like to welcome Erasmus students Aiofe Davis & Navya Lalu, Master student Kristina Mojtic, Research assistant Krista Stenstrøm and visiting researcher Soumik Ray to the group!
-
We are continuing our journey to a more sustainable way to do our exciting research with our recently awarded LEAF Silver certificate. Many thanks to the members of the group for their great help and efforts to reach this goal.
-
Jesper Elmsted Dreier received a 695 € travel grant from the Federation of European Biochemical Societies (FEBS) to attend the FEBS Advanced Lecture Course entitled “Protein folding, aggregation and compartmentalization”.
-
The Friday bar is a social initiative for employees, PhD Students and students writing their master’s thesis at a department. Last Friday, we enjoyed some live music, food, drinks and good company under the summer sun.
-
Céline Galvagnion received a DKK 2,879,534 grant from Danmarks Frie Forskningsfond for the project “Understanding the cytotoxicity of protein-lipid aggregates in Parkinson’s Disease”. This project aims to investigate the toxicity of protein-lipid aggregates and fibrils in different cellular models of Parkinson’s Disease.
-
Céline Galvagnion and her partners received a 1.749.377 € collaborative grant from EraPermed for the project “DEEPEN-iRBD Prodromal DEtErminants for PhENoconversion of idiopathic RBD to alpha-synucleinopathies (PD, DLB and MSA)”. The DEEPEN-iRBD study aims to model the progression of REM sleep behaviour disorder (RBD) towards Parkinson’s disease (PD), multiple system atrophy (MSA) and dementia with Lewy bodies (DLB). The DEEPEN-iRBD study is coordinated by Graziella Cappelletti from the University of Milan and involves partners from Milan Maugeri Clinical Science Institute, the Lund University, the French National Centre for Scientific Research, the Danish Parkinson’s Association and the University of Zagreb. (Twitter; LinkedIn)
-
Celine gave a talk at the 8th Spring symposium of Center for Medicinal Chemistry on the 25th of May 2023 discussing the lipid changes associated with α-synuclein and Parkinson’s Disease pathology.
-
We are excited about Céline being part of the Basic Science Subcommittee in the upcoming World Parkinson Congress that will take place in Barcelona from the 4th until the 7th of July 2023. The World Parkinson Congresses, serve as a global platform where basic scientists, clinical researchers, healthcare professionals, individuals with Parkinson’s, and other stakeholders convene to foster discussions, knowledge exchange, and constructive debates on the most recent scientific breakthroughs, medical advancements, and comprehensive care practices concerning Parkinson’s disease. Read more about it →
Galvagnion Group 